Company · CIK 0000200406 · SIC 2834 — Pharmaceutical Preparations · NYSE
JOHNSON & JOHNSON · JNJ
Insider activity reported against this company. All insider holders · Files at: PRVB, INSP, ACHN, NERV, PTGX, NVRO, NGNE. On EDGAR ↗
Reported at this company — common stock
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 2, 2026 SForm 4 → | Sep 4, 9:08 am EDT | Timothy SchmidEVP, WW Chair, MedTech | 33,597 | $274.74 | $9,230,440 | 25,447 | −56.9% | |
| Sep 2, 2026 MForm 4 → | Sep 4, 9:08 am EDT | Timothy SchmidEVP, WW Chair, MedTech | 33,597 | $144.99 | $4,871,389 | 47,974 | — | |
| Aug 17, 2026 SForm 4 → | Aug 18, 6:31 pm EDT | Jennifer L TaubertEVP, WWC. Innovative Medicine | 15,000 | $263.36 | $3,950,400 | 194,451 | −7.16% | |
| Aug 17, 2026 MForm 4 → | Aug 18, 6:31 pm EDT | Jennifer L TaubertEVP, WWC. Innovative Medicine | 15,000 | $115.67 | $1,735,050 | 209,451 | — | |
| Aug 13, 2026 SForm 4 → | Aug 14, 4:35 pm EDT | Joaquin DuatoCEO and Chairman of the Board, Director | 123,291 | $261.17 | $32,199,927 | 275,967 | −30.9% | |
| Aug 13, 2026 MForm 4 → | Aug 14, 4:35 pm EDT | Joaquin DuatoCEO and Chairman of the Board, Director | 123,291 | $115.67 | $14,261,070 | 399,258 | — | |
| Aug 6, 2026 SForm 4 → | Aug 7, 5:44 pm EDT | Elizabeth ForminardEVP, Chief Legal Officer | 15,918 | $257.00 | $4,090,960 | 16,994 | −48.4% | |
| Aug 6, 2026 MForm 4 → | Aug 7, 5:44 pm EDT | Elizabeth ForminardEVP, Chief Legal Officer | 9,344 | $131.94 | $1,232,847 | 32,912 | — | |
| Aug 5, 2026 SForm 4 → | Aug 7, 5:50 pm EDT | Joaquin DuatoCEO and Chairman of the Board, Director | 48,480 | $258.15 | $12,515,010 | 275,967 | −14.9% | |
| Jul 20, 2026 SForm 4 → | Jul 21, 5:27 pm EDT | Vanessa BroadhurstEVP, Global Corp Affairs | 23,054 | $251.27 | $5,792,686 | 23,003 | −50.1% | |
| Jul 20, 2026 MForm 4 → | Jul 21, 5:27 pm EDT | Vanessa BroadhurstEVP, Global Corp Affairs | 23,054 | $130.77 | $3,014,701 | 46,057 | — | |
| Jun 11, 2026 SForm 4 → | Jun 12, 5:23 pm EDT | Kathryn E WengelEVP, Chief TO and Risk Officer | 10,000 | $241.15 | $2,411,500 | 114,288 | −8.05% | |
| Jun 11, 2026 MForm 4 → | Jun 12, 5:23 pm EDT | Kathryn E WengelEVP, Chief TO and Risk Officer | 10,000 | $115.67 | $1,156,700 | 124,288 | — |
Reported at this company — derivatives (options, RSUs, warrants)
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 8, 2026 AForm 4 → | Sep 10, 8:51 pm EDT | Daniel E PintoDirector | 113 | $276.31 | $31,250 | 2,445 | — | |
| Sep 8, 2026 AForm 4 → | Sep 10, 8:50 pm EDT | Eugene A. WoodsDirector | 136 | $276.31 | $37,500 | 6,579 | — | |
| Sep 8, 2026 AForm 4 → | Sep 10, 8:50 pm EDT | Marillyn A HewsonDirector | 181 | $276.31 | $50,000 | 16,049 | — | |
| Sep 2, 2026 MForm 4 → | Sep 4, 9:08 am EDT | Timothy SchmidEVP, WW Chair, MedTech | 33,597 | — | — | 0 | — | |
| Aug 17, 2026 MForm 4 → | Aug 18, 6:31 pm EDT | Jennifer L TaubertEVP, WWC. Innovative Medicine | 15,000 | — | — | 28,712 | — | |
| Aug 13, 2026 MForm 4 → | Aug 14, 4:35 pm EDT | Joaquin DuatoCEO and Chairman of the Board, Director | 123,291 | — | — | 0 | — | |
| Aug 6, 2026 MForm 4 → | Aug 7, 5:44 pm EDT | Elizabeth ForminardEVP, Chief Legal Officer | 9,344 | — | — | 0 | — | |
| Jul 20, 2026 MForm 4 → | Jul 21, 5:27 pm EDT | Vanessa BroadhurstEVP, Global Corp Affairs | 23,054 | — | — | 0 | — | |
| Jun 11, 2026 MForm 4 → | Jun 12, 5:23 pm EDT | Kathryn E WengelEVP, Chief TO and Risk Officer | 10,000 | — | — | 32,965 | — | |
| Jun 9, 2026 AForm 4 → | Jun 11, 4:56 pm EDT | Eugene A. WoodsDirector | 161 | $232.79 | $37,500 | 6,412 | — | |
| Jun 9, 2026 AForm 4 → | Jun 11, 4:43 pm EDT | Daniel E PintoDirector | 134 | $232.79 | $31,250 | 2,321 | — | |
| Jun 9, 2026 AForm 4 → | Jun 11, 4:35 pm EDT | Marillyn A HewsonDirector | 215 | $232.79 | $50,000 | 15,792 | — |
Filed by this entity as an insider elsewhere — common stock
No reported common-stock activity in this period.
Filed by this entity as an insider elsewhere — derivatives (options, RSUs, warrants)
No reported derivative activity in this period.